Keyphrases
Secondary Hyperparathyroidism
97%
Intact Parathyroid Hormone (iPTH)
86%
Hemodialysis
76%
Hemodialysis Patients
58%
Chronic Kidney Disease
50%
Dialysis
47%
1-α(OH)D3
44%
Alfacalcidol
42%
Uremic Patients
37%
Paricalcitol
34%
Vitamin D Analogs
32%
Parathyroid Hormone Levels
32%
High Dose
30%
1,25(OH)2D3
30%
End-stage Renal Disease
29%
Low Calcium
28%
End-stage Kidney Disease
27%
Ca2+
27%
Dialysate
27%
Magnesium Supplementation
26%
Randomized Clinical Trial
26%
Vascular Calcification
24%
Hypercalcemia
23%
Chronic Hemodialysis
23%
Calcium Concentration
22%
Denmark
21%
Hyperphosphatemia
21%
Cardiovascular Mortality
20%
Magnesium
19%
Intradialytic
19%
Serum Calcification Propensity
19%
Placebo
18%
Phosphate Kinetics
17%
Cholecalciferol
17%
COVID-19
17%
Dialysate Magnesium
17%
Parathyroid Tissue
17%
Total Parathyroidectomy
17%
Continuous Ambulatory Peritoneal Dialysis
17%
Autotransplantation
17%
Kinetic Model
17%
Randomized Controlled Clinical Trial
17%
Vitamin D
15%
Fibroblast Growth Factor 23 (FGF23)
14%
Maintenance Hemodialysis
14%
Dialysis Solutions
13%
Mg Magnesium
13%
Inflammatory Markers
13%
Autograft
13%
Phosphate
13%
Medicine and Dentistry
Parathyroid Hormone
93%
Hemodialysis
78%
Secondary Hyperparathyroidism
69%
Isotopes of Calcium
54%
End Stage Renal Disease
41%
Dialysis Fluid
40%
Magnesium
37%
Continuous Ambulatory Peritoneal Dialysis
37%
Chronic Kidney Disease
34%
Alfacalcidol
33%
Parathyroidectomy
20%
Randomized Clinical Trial
19%
Hormone Determination
19%
Calcium Ion
18%
Supplementation
18%
Blood Vessel Calcification
18%
COVID-19
17%
Controlled Clinical Trial
17%
Autotransplantation
17%
Parathyroid
17%
Aragonite
17%
Hyperphosphatemia
15%
Hypercalcaemia
14%
Vitamin D
14%
Infection
13%
Uremia
13%
Autograft
13%
Cardiovascular Disease
13%
Cardiovascular Mortality
11%
Vitamin D Analog
11%
Clinical Study
11%
Heart Disease
9%
Carboxy Terminal Sequence
9%
Pharmacokinetics
9%
Volunteer
9%
Neonatal Infant
8%
Incretin
8%
Observational Study
8%
Cord Blood
8%
Acid Base Balance
8%
Nephropathy
8%
Paricalcitol
8%
Lavage
8%
Endocrine Pancreas
8%
Peritonitis
8%
Venous Blood
8%
Hydration Status
8%
Renal Cortical Necrosis
8%
T Cell
8%
Peritoneal Dialysis Fluid
8%
Pharmacology, Toxicology and Pharmaceutical Science
Hemodialysis
100%
Secondary Hyperparathyroidism
90%
Parathyroid Hormone
77%
Alfacalcidol
58%
End Stage Renal Disease
41%
Chronic Kidney Failure
34%
Paricalcitol
34%
Placebo
28%
Vitamin D
27%
Vitamin D Analog
26%
Hypercalcaemia
23%
Hyperphosphatemia
21%
Calcium Ion
20%
Randomized Clinical Trial
19%
Dialysis Fluid
19%
Controlled Clinical Trial
17%
Blood Vessel Calcification
14%
Dialysis Fluid
14%
Fibroblast Growth Factor 23
13%
Uremia
13%
Cardiovascular Disease
12%
Calcium Carbonate
12%
Cardiovascular Mortality
11%
Normal Human
10%
Clinical Study
10%
Incretin
8%
Cholecalciferol
8%
Functional Status
8%
Disease
8%
Kidney Disease
8%
Rapidly Progressive Glomerulonephritis
8%
Kidney Cortex Necrosis
8%
Coronavirinae
8%
Peritonitis
8%
Peritoneal Dialysis Fluid
8%
Hydration
8%
Hydroxycolecalciferol
8%
Erythropoietin
8%
Brain Natriuretic Peptide
8%
Glucocorticoid
8%
Deflazacort
8%
Prednisone
8%
Infection
8%
Hypervolemia
6%
Hypotension
6%
Phytohaemagglutinin
6%
Diastolic Dysfunction
6%
Phosphate Binding Agent
6%
Recombinant Erythropoietin
5%
Acute Kidney Failure
5%
